Form 8-K - Current report:
SEC Accession No. 0001005286-24-000138
Filing Date
2024-09-23
Accepted
2024-09-23 16:14:54
Documents
13
Period of Report
2024-09-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11

Document Format Files

Seq Description Document Type Size
1 8-K lndc-20240923.htm   iXBRL 8-K 28410
  Complete submission text file 0001005286-24-000138.txt   152803

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lndc-20240923.xsd EX-101.SCH 1983
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lndc-20240923_lab.xml EX-101.LAB 21885
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lndc-20240923_pre.xml EX-101.PRE 12591
15 EXTRACTED XBRL INSTANCE DOCUMENT lndc-20240923_htm.xml XML 2690
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

EIN.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0525
Type: 8-K | Act: 34 | File No.: 000-27446 | Film No.: 241316386
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)